RxDoctor Payments Data

Ankit Desai, MD

Plastic and Reconstructive Surgery · Jacksonville, FLNPI 1932302387

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (46.9%), other and travel and lodging — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Surgical Innovation Associates, Inc. at 29.1% of the total.

$13,122in general payments, 2019–2025

Across 145 payments — averaging $90.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Surgical Innovation Associates, Inc.$4K
  • Mentor Worldwide LLC$2K
  • Axogen$2K
  • AbbVie$2K
  • Musculoskeletal Transplant Foundation Inc.$1K
  • TELA Bio, Inc.$223
  • plus $2K from 28 others

What the payments were for

  • Grants$1721%
  • Travel & lodging$1,76513%
  • Food & beverage$6,15347%
  • Gifts$1,2109%
  • Other$3,82229%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,122 in reported general payments places this provider in the 80th percentile of 235 plastic and reconstructive surgery providers in Florida.

See all plastic and reconstructive surgery providers in Florida

Medicare billing

Part B allowed, 2024
$90,402
Medicare patients
91
Services billed
270

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron69$661
Mupirocin99$643
CefuroximeCefuroxime Axetil59$588
Ibuprofen85$356
Cyclobenzaprine Hcl40$231
Gabapentin74$210
Doxycycline Hyclate19$158
Methocarbamol23$86

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →